Improving perinatal Group B streptococcus screening with process indicators
| Autor: | M. Albouy-Llaty, Virginie Migeot, Fabrice Pierre, Emmanuelle Descombes, Cédric Nadeau |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Pediatrics Pregnancy 030219 obstetrics & reproductive medicine business.industry Streptococcus Obstetrics Health Policy Public Health Environmental and Occupational Health Group B Streptococcus Screening medicine.disease_cause medicine.disease Group B 3. Good health 03 medical and health sciences Neonatal infection 0302 clinical medicine 030225 pediatrics Medicine Gestation Antibiotic prophylaxis Young adult business reproductive and urinary physiology |
| Zdroj: | Journal of Evaluation in Clinical Practice. 18:727-733 |
| ISSN: | 1356-1294 |
| Popis: | Rationale Group B streptococcus (GBS) neonatal infection can be prevented by screening pregnant women for GBS colonization from the 34th to the 38th week of gestation, as has been recommended in France since 2001. We assessed guideline adherence among midwives and obstetricians. Methods From 2006 to 2008, new and mandatory GBS data were added to the obstetric database. We merged the latter with a bacteriological database and a paediatric database and defined process indicators for pregnant women who delivered from the 37th week of gestation in the hospital of Poitiers and for neonates hospitalized for a GBS infection from 2006 to 2008. Results We abstracted 5997 pregnant women (1942 in 2006, 1975 in 2007 and 2080 in 2008) and 84 neonates (17 in 2006, 32 in 2007 and 35 in 2008). GBS pregnancy colonization prevalence was 15%, 13% and 18% respectively. Availability of GBS screening status was stable (96%, P = 0.15). The rate of GBS screening during pregnancy increased significantly (86% to 90%, P = 0.002). Percentage of correct-term screening increased significantly (89% to 96%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text